Marksans Pharma Limited
L24110MH1992PLC066364ActivePublic · Non-govt companyRoC-MumbaiListed
Last updated: 2026-06-08
67
Compliance Health · C · provisional
3 / 4 signals passed
Marksans Pharma Limited is a Public Non-govt company company incorporated in 1992 and based in Maharashtra, India. Marksans Pharma Limited operates in Pharmaceuticals & Chemicals (NIC 24110) with authorized capital of ₹69.00 Cr and paid-up capital of ₹40.93 Cr. For 2025-26, the company reported revenue of ₹1341.48 Cr and profit after tax of ₹300.70 Cr. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Risk FlagsDirectors not yet extracted · awaiting MGT-7AGM 1784d ago · may be overdue
Revenue (latest FY)
₹1341.48 Cr
2025-26
PAT (latest FY)
₹300.70 Cr
Margin 22.4%
Open Charges
0
No encumbrances
Active Directors
0
No resignations
Paid-up Capital
₹40.93 Cr
59% of authorized
Filings on Record
0
All current
Incorporated
1992
34 years old
State
Maharashtra
Sector
Pharmaceuticals & Chemicals
NIC 24110
Class
Public
Sub-category
Non-govt company
Authorized Capital
₹69.00 Cr
Paid-up Capital
₹40.93 Cr
59% utilized
Members
11992
Last AGM
23 Sept 2021
1784d ago
Last Balance Sheet
31 Mar 2021
1960d ago
Latest Filing
—
Registered Email
h************(at)marksanspharma.com
Registered Office
11th Floor, GRANDEUR, Veera Desai Extension Road Oshiwara, Andheri (W) Mumbai Mumbai City MH 400053 IN
Quick facts
Registered office
11th Floor, GRANDEUR, Veera Desai Extension Road Oshiwara, Andheri (W) Mumbai Mumbai City MH 400053 IN
NIC code
24110
Statutory auditor
Awaiting ADT-1 / AOC-4 extraction
Registered email
h************(at)marksanspharma.com
Section
Pharmaceuticals & Chemicals
ROC
RoC-Mumbai
Website
—
Class · sub-category
Public · Non-govt company
Incorporation · Last AGM
16 Apr 1992 · 23 Sept 2021
Directors
LockedSG
Sneha Gupta
Director1.9y · Ahmedabad · DIN 5868184
PN
Priya Nair
Additional Director6.2y · Bengaluru · DIN 5910849
SI
Suresh Iyer
Managing Director2.2y · Hyderabad · DIN 4032254
DR
Deepa Reddy
Whole-time Director4.9y · Bengaluru · DIN 7077201
Get the full board of directors
Directors, DINs & appointment history for Marksans Pharma Limited.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 25 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 23 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 20 Nov 2022 | 29 Nov 2022 | 0d | filed |
Get financial statements & other filing documents
Full MCA filing history for Marksans Pharma Limited.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 869612470 | State Bank of India(Bank) | ₹20.27 Cr | 19 Sep 2021 | Open |
| 709489181 | State Bank of India(Bank) | ₹14.26 Cr | 19 Sep 2020 | Satisfied |
| 537861813 | Axis Bank Ltd(Bank) | ₹12.84 Cr | 19 Sep 2023 | Open |
| 393594944 | ICICI Bank Ltd(Bank) | ₹18.01 Cr | 04 Jul 2019 | Open |
| 400655395 | Axis Bank Ltd(Bank) | ₹23.50 Cr | 19 Sep 2021 | Satisfied |
See registered charges & lenders
Charge IDs, lenders & amounts for Marksans Pharma Limited.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCARevenue (bars) vs PAT (line) by FY
Revenue PAT
| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2025-26 | — | ||||
| 2015-16 | — |
Detailed Financials
2 FYs| Line item | 2025-26 | 2015-16 |
|---|---|---|
| Income statement | ||
| Revenue from operations | ||
| Other income | ||
| Total income | ||
| Total expenses | ||
| Profit before tax | ||
| Profit / (Loss) after tax | ||
| Balance sheet | ||
| Equity / Net worth | ||
| Borrowings | ||
| Current liabilities | ||
| Total liabilities | ||
| Current assets | ||
| Cash & equivalents | ||
| Total assets | ||
| Employees | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2025-26 | +940.0% | — | — | |
| Profit after Tax2025-26 | +369.0% | — | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2015-16 | +19.49% | — | +16.91% | +13.38% | — | |||
| 2025-26 | +22.42% | +265.71% | — | — | — |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 1 | 50,86,816 | 84.32% |
| Institutional Investors | 1 | 4,14,997 | 6.88% |
| Public & Others | 10 | 5,30,647 | 8.80% |
See the full shareholding pattern
Promoter, institutional & public holding for Marksans Pharma Limited.
What you'll get
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
116 peersMetricThis companyCohort medianCohort P75Quartile
Revenue (latest FY)
Top quartile · P96
PAT (latest FY)
Top quartile · P98
Employees
—
—
—
—
Paid-up capital
Top quartile · P98
Compliance Health
96
96
96
Bottom quartile · P13
Events & timeline
323 Sept 2021
Meena appointed as Director
29 Sept 2020
Varddhman appointed as Director
16 Apr 1992
Company incorporated
Marksans Pharma Limited registered with RoC-Mumbai; year 1992
External data sources
7 plannedGSTIN Registrations
GST portal
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
MSME-1 form
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
AOC-4 schedule
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
CRISIL / ICRA / CARE feeds
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
IP India Trademark Registry
Applied, registered, opposed. Class numbers + status.
Patents
IP India Patent Registry
Applications and grants. Inventor names + filing dates.
Legal Cases
eCourts + Indian Kanoon
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.
FAQs about Marksans Pharma Limited
When was Marksans Pharma Limited incorporated?
Marksans Pharma Limited was incorporated in 1992 (around 16 Apr 1992). Its CIN is L24110MH1992PLC066364 and it is registered with RoC-Mumbai.
Where is Marksans Pharma Limited located?
Marksans Pharma Limited is headquartered in Maharashtra, at: 11th Floor, GRANDEUR, Veera Desai Extension Road Oshiwara, Andheri (W) Mumbai Mumbai City MH 400053 IN .
What sector does Marksans Pharma Limited operate in?
Marksans Pharma Limited operates in the Pharmaceuticals & Chemicals sector (NIC code 24110), classified as Non-govt company.
Who are the directors of Marksans Pharma Limited?
Director details for Marksans Pharma Limited have not yet been extracted from MGT-7 filings.
What is the paid-up capital of Marksans Pharma Limited?
Marksans Pharma Limited has authorized capital of ₹69.00 Cr and paid-up capital of ₹40.93 Cr.
Does Marksans Pharma Limited have any open charges?
Marksans Pharma Limited has no open MCA-registered charges on record.
What is Marksans Pharma Limited's Compliance Health Score?
RegisterKaro's Compliance Health Score for Marksans Pharma Limited is 67/100 (grade C), based on 4 assessable weighted signals across charges, directors, capital, and overall status. 3 of 4 passed — this is a provisional score; full scoring is pending extraction of the company's MCA filing history.